Why Liposomal Delivery Outperforms Standard Formats – and Where It Doesn't

Why Liposomal Delivery Outperforms Standard Formats – and Where It Doesn’t

“Liposomal” has become one of the most overused words on a supplement label, which is unfortunate, because the underlying science is genuinely well established. The gap between the two – real encapsulation technology and the marketing use of the word – is exactly where a brand’s due diligence needs to sit before choosing a manufacturing partner.

What encapsulation actually does?

A liposome is a microscopic sphere built from phospholipids – the same molecules that make up the membrane of every cell in the human body. That structure gives it a useful property: phospholipids are amphiphilic, meaning one end is water-loving and the other is fat-loving, which lets a liposome fold itself around water-soluble actives in its core and fat-soluble actives within the bilayer wall itself, sometimes both at once. Because the shell is built from the same material as a cell membrane, it can pass through the gut wall in a way that a bare, unprotected molecule often can’t.

In practice, that means the active ingredient travels through digestion inside a protective shell instead of exposed to it directly.

Where the benefit is real and measurable?

Acid and enzyme protection. Stomach acid sits at a pH of roughly 1.5–4, hostile territory for a lot of nutrients, and pancreatic enzymes further downstream break down anything unprotected before it reaches an absorption site. The phospholipid bilayer acts as a physical barrier through that entire stretch.

Absorption gains for specific, well-studied actives. This is where the evidence is strongest, and it’s active-specific rather than a universal multiplier. A 2026 randomised trial measured over twenty-fold higher plasma exposure for nano-liposomal curcumin versus free curcumin at a lower dose – consistent with curcumin’s known poor native bioavailability. For glutathione, a small clinical trial found liposomal delivery raised whole-blood levels by around 40% after a month, something plain oral glutathione typically fails to do.

Stability for fragile actives. The same bilayer that blocks acid also blocks oxygen and light, which matters for actives that degrade on exposure to either – a meaningful production and shelf-life advantage, not just a digestive one.

Dual solubility in one system. Because a single liposome can carry both hydrophilic and lipophilic material, it’s one of the few delivery formats that can combine actives with very different solubility profiles into a single stable product, rather than requiring separate formats for each.

Lower GI irritation. Encapsulating an active also physically separates it from direct contact with the stomach lining during transit – relevant for actives like iron that are well known to cause GI discomfort in unprotected forms.

Why does the claim need to be checked, not just made?

None of this means the word “liposomal” on a label is a reliable signal by itself, and a technical piece that doesn’t say so isn’t being straight with its readers. No regulator – not the FDA, not the EU – currently defines what a product has to contain to legally call itself “liposomal.” Independent testing has repeatedly found commercial “liposomal” products with no verifiable liposomes at all – sometimes simple emulsions or micelles – and unpublished “10x” or “100x” absorption claims are common in the category.

Not every active has the same weight of evidence behind it. Curcumin and glutathione, above, are individually well-studied. But most research tests one active at a time – when several actives are combined into a single liposomal product, there’s far less data on whether the combination absorbs the same way. A late-2025 study looked at exactly that: a multi-nutrient liposomal formula. It raised no safety concerns, but confirmed that solid absorption data for combined formulas specifically is still thin. For some single actives, liposomal delivery is proven. For a multi-nutrient blend, or a lower price point, a standard format can still be the safer bet.

Science meets the manufacturing

The practical takeaway for a brand evaluating a manufacturing partner isn’t “does this supplier offer liposomal,” it’s “can this supplier show encapsulation efficiency and absorption data for the specific active in question.” Those aren’t the same question, and the gap between them is where most of the category’s credibility problem lives.

Noviatic’s patented liposomal system, Miosol™, is applied to a defined set of actives – ferrum, glutathione, CoQ10, curcumin, vitamin D3, K2 and B12 – each tested and confirmed on its own, rather than absorption being assumed simply because a product is labelled “liposomal.” Learn more about Noviatic’s Miosol™ liposomal manufacturing capabilities.

The right question isn’t whether liposomal delivery works. It’s whether the specific product in front of you can prove that it does.